Skip to main content
Clinical Trials/JPRN-UMIN000012895
JPRN-UMIN000012895Completed未知

Investigation on bronchoalveolar lavage technique as an evaluation of drug migration to lung tissue - Investigation on bronchoalveolar lavage technique as an evaluation of drug migration to lung tissue

Medical Co. LTA Clinical Pharmacology Center0 sites6 target enrollmentStarted: January 18, 2014Last updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
6

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 45years-old (—)
Sex
Male

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1, Subject who has allergy or had hypersensitivity to lidocaine and/or azithromycin hydrate. And/or subject with illness which prohibits administration of these substances. 2, Subject with history of drug allergy. 3, Subject who received medical treatment 2 months prior to BAL. 4, Subject who donated more than 400ml or 200ml of blood within 3 months or 1 month prior to BAL, respectively. 5, Subject whose result of screening examinations (include vital sign, 12-lead ECG, and safety laboratory tests) deviates from reference range, and the deviation is judged clinically significant by study physician. 6, Subject who takes drug habitually and/or who abuses alcoholic beverage. 7, Subject who acquired severe medical illness within 4 months prior to BAL. 8, Subject with positive test results of syphilis, HIV antigen/antibody, HBs antigen, and/or HCV antibody. Or subject with sign of infection. 9, Subject who smokes within 6 months prior to BAL. 10, Subject who are considered to be inadequate for this study by study physician.

Investigators

Sponsor
Medical Co. LTA Clinical Pharmacology Center

Similar Trials